CVS HEALTH CORPORATION Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
CVS HEALTH CORPORATION (CVS) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $110.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-09.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2016-02-09
- CVS HEALTH CORPORATION valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2015 was $110.00M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2015-12-31 | $110.00M 10-K · filed 2016-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |